Citations

Institution: Mayo Clinic Clear

Showing 10 of 108104 citations.

New issues in the pathogenesis of hepatocellular carcinoma: Applying insights from next-generation DNA sequencing technologies to improve therapy for hepatocellular carcinoma
Chaiteerakij, Roongruedee , Roberts, Lewis R.

Clinical Liver Disease | January 23, 2013 | Volume: 1 | Issue: 6 | Pages: 200-205

10.1002/cld.113 | PMID 31186887 Get It

Can Digital Breast Tomosynthesis Replace Conventional Diagnostic Mammography Views for Screening Recalls Without Calcifications? A Comparison Study in a Simulated Clinical Setting
Brandt, Kathleen R. , Craig, Daniel A., Hoskins, Tanya L., Henrichsen, Tara L. , Bendel, Emily C. , Brandt, Stephanie R., Mandrekar, Jay

American Journal of Roentgenology | January 23, 2013 | Volume: 200 | Issue: 2 | Pages: 291-298

10.2214/ajr.12.8881 | PMID 23345348 Get It

Diagnosis and Management of Cystic Pancreatic Lesions
Sahani, Dushyant V., Kambadakone, Avinash, Macari, Michael, Takahashi, Naoki , Chari, Suresh T. , Castillo, Carlos Fernández‐del , Takahashi, Naoki , Chari, Suresh T

American Journal of Roentgenology | January 23, 2013 | Volume: 200 | Issue: 2 | Pages: 343-354

10.2214/ajr.12.8862 | PMID 23345356 Get It

Renal Epithelioid Angiomyolipoma: Imaging Characteristics in Nine Cases With Radiologic-Pathologic Correlation and Review of the Literature
Froemming, Adam T. , Boland, Jennifer M. , Cheville, John C. , Takahashi, Naoki , Kawashima, Akira , Takahashi, Naoki

American Journal of Roentgenology | January 23, 2013 | Volume: 200 | Issue: 2 | Pages: W178-W186

10.2214/ajr.12.8776 | PMID 23345382 Get It

Percutaneous Ablation of Renal Masses Measuring 3.0 cm and Smaller: Comparative Local Control and Complications After Radiofrequency Ablation and Cryoablation
Atwell, Thomas D. , Schmit, Grant D. , Boorjian, Stephen A. , Mandrekar, Jay , Weisbrod, Adam J. , Chow, George K. , Leibovich, Bradley C. , Callstrom, Matthew R. , Patterson, David E., Lohse, Christine M. , Thompson, R. Houston, Kurup, A. Nicholas

American Journal of Roentgenology | January 23, 2013 | Volume: 200 | Issue: 2 | Pages: 461-466

10.2214/ajr.12.8618 | PMID 23345372 Get It

Incidence of Radiographic Cam-Type Impingement in Young Patients (
Wendt, Matthew C., Cass, Joseph R., Trousdale, Robert R.

HSS Journal®: The Musculoskeletal Journal of Hospital for Special Surgery | January 23, 2013 | Volume: 9 | Issue: 2 | Pages: 113-117

10.1007/s11420-012-9325-5 | PMID 24426855 Get It

Background Cam-type femoral impingement is caused by structural abnormalities of the hip and is recognized as a cause of degenerative hip arthritis. Identifiable etiologies of this structural abnormality include congenital malformation, pediatric hip disease, and malunion of femoral neck fractures after internal fixation. Purpose The purpose of this study was to determine the prevalence of radiographic impingement in healed Orthopaedic Trauma Association (OTA) type 31B fractures treated with reduction and internal fixation. Methods Seventy OTA 31B hip fractures treated with internal fixation were identified from our institutional trauma database and radiographs were retrospectively reviewed for signs of impingement. Mean follow-up was 53 months after fracture. Alpha angle, Mose templates, and femoral head retroversion were the measurements used to determine impingement. Results The overall prevalence of any sign of radiographic impingement was 75%. Alpha angle was elevated in 32 hips (46%), asphericity was present in 46 femoral heads (65%), and femoral head retroversion was present in 26 hips (37%). The rates were highest in displaced subcapital fractures (OTA 31B-3) with a 63% (13/19) prevalence of elevated alpha angle, 68% (14/19) prevalence of asphericity, and 47% (10/19) prevalence of retroversion. Conclusions Prevalence of radiographic signs of impingement in this population is higher than expected based on population-based controls. Surgeons must be vigilant about reduction and fixation of femoral neck fractures. Malunion should be recognized as early intervention may be beneficial in improving long-term outcomes.
Caution Should be Taken in Performing Surgical Hip Dislocation for the Treatment of Femoroacetabular Impingement in Patients over the Age of 40
Boone, Gregory, Pagnotto, Michael R., Walker, Jessica, Trousdale, Robert T. , Sierra, Rafael J.

HSS Journal®: The Musculoskeletal Journal of Hospital for Special Surgery | January 23, 2013 | Volume: 8 | Issue: 3 | Pages: 230-234

10.1007/s11420-012-9306-8 | PMID 24082865 Get It

Background Open and arthroscopic procedures are treatment options for patients with femoroacetabular impingement (FAI). Age has been found to be a predictive factor in the outcome of patients undergoing periacetabular osteotomy (PAO) for hip dysplasia. It is unclear if older age contraindicates joint preservation through a surgical hip dislocation (SHD). Questions/Purpose The purpose of this retrospective case series was to evaluate the short-term outcomes of patients over 40 years of age without radiographic evidence of end-stage arthritis who underwent SHD for the treatment of FAI and to determine whether older age should be a contraindication for joint-preserving procedures in these patients. Our specific aims included (1) documenting the intraoperative findings and procedures, (2) assessing pain relief provided, and (3) assessing treatment failures and postoperative complications, noting the number of patients that ultimately required total hip arthroplasty (THA). Patients and Methods All patients at age 40 and older who had SHD for the treatment of FAI were identified from a series of patients treated with SHD. Clinical notes, radiographs, and operative reports were reviewed to determine clinical results, complications, and the need for additional procedures. The minimum follow-up was 1 year (mean 3.9 years; range 1–8 years). Results At final follow-up, 11/22 (50%) of hips had pain relief, while 11/22 (50%) either continued having significant symptoms or required THA. Five (23%) reported nontrochanteric pain symptoms that were the same or worse than before surgery, and six hips (27%) underwent subsequent THA). The average time between SHD and THA was 1.9 years (0.9–6.2). The average age of patients who went on to require THA was 45 (42–50) years. Conclusions Surgical hip dislocation can be used for the treatment of FAI in patients over age 40, but strict selection criteria should be adhered to, as only half of the patients experienced significant improvement in their hip pain. THA was required in one-third of hips for continued pain and radiographic progression of arthritis. SHD for treatment of pathology that is not amenable to hip arthroscopy should remain a surgical option in older patients with FAI only if joint degeneration is not present.
A Surrogate for Topical Delivery in Human Skin: Silicone Membranes
Sloan, Kenneth B., Synovec, Jennifer, Ketha, Hemamalini

Therapeutic Delivery | January 23, 2013 | Volume: 4 | Issue: 2 | Pages: 203-224

10.4155/tde.12.131 | PMID 23343160 Get It

The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole
Barreto, Jason N. , Beach, Cassidy, Merten, Julianna A., Tosh, Pritish K. , Wilson, John , Litzow, Mark R. , Wolf, Robert Christian , Hogan, William J.

American Journal of Hematology | January 23, 2013 | Volume: 88 | Issue: 4 | Pages: 283-288

10.1002/ajh.23388 | PMID 23460251 Get It

The objective of this study is to characterize the outcomes of primary antifungal prophylaxis with voriconazole in patients receiving intensive chemotherapy for acute myelogenous leukemia (AML) or myelodysplastic syndromes (MDS). We conducted a single center, retrospective, cohort study of consecutive adult patients with AML or MDS at Mayo Clinic between January 1, 2006 and July 1, 2010. The study included patients undergoing induction or first relapse combination chemotherapy who received voriconazole 200 mg orally twice daily as prophylaxis during the neutropenic phase. Patient records were evaluated until 30 days after neutrophil recovery for development of invasive fungal infection (IFI) as defined per EORTC/MSG 2008 criteria with computed tomography scans independently reviewed by a radiologist. Therapeutic drug monitoring and reasons for voriconazole discontinuation were documented. Twenty four episodes of IFI were detected among 165 consecutive patients for an overall incidence of 145 per 1000 patients. The incidence of IFI was 24, 42, and 78 per 1000 patients for proven, probable, and possible infection, respectively. Four patients developed proven IFI (n = 2 Aspergillus spp., n = 2 Rhizopus spp.). Serum voriconazole trough concentrations were available in 39 patients, and no statistically significant difference in voriconazole trough level was observed between those with versus without an IFI. Voriconazole prophylaxis was discontinued in 81 patients due to suspected IFI (n = 24), fever of unknown origin (n = 19), adverse events (n = 23), and other causes (n = 17). Voriconazole as primary IFI prophylaxis is safe and may be beneficial in AML/MDS patients receiving intensive chemotherapy. Am. J. Hematol. 88:283–288, 2013. © 2013 Wiley Periodicals, Inc.
Association of Microvascular and Capillary-Lymphatic Invasion with Outcome in Patients with Renal Cell Carcinoma
Eisenberg, Manuel S., Cheville, John C. , Thompson, R. Houston, Kaushik, Dharam , Lohse, Christine M. , Boorjian, Stephen A. , Costello, Brian A. , Leibovich, Bradley C.

Journal of Urology | January 23, 2013 | Volume: 190 | Issue: 1 | Pages: 37-43

10.1016/j.juro.2013.01.044 | PMID 23353044 Get It